CRSP vs VRTX
CRSP 与 VRTX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | CRSPCRISPR THERAPEUTICS AG | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| 市值 | $4.63B | $121.07B |
| 市盈率(TTM) | — | 28.3 |
| 市净率 | — | 6.25 |
| 市销率 | 1315.9x | 10.0x |
| 营收 | — | $12.22B(TTM) |
| 营收同比增长 | -90.6% | 8.9% |
| 净利润 | — | $4.34B(TTM) |
| 净利同比增长 | -58.8% | 838.1% |
| 每股收益(稀释) | — | $16.85(TTM) |
| 息税前利润率 | -18933.6% | 34.8% |
| 净资产收益率 | -32.1% | 20.4% |
| 投入资本回报率 | -33.6% | 25.4% |
| 一年总回报 | -14.8% | +3.5% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:CRSP vs VRTX
| 指标 | CRSP | VRTX |
|---|---|---|
| 期末价值 | $34.1K | $58.3K |
| 总回报 | +240.6% | +483.0% |
| 年化收益 (CAGR) | +13.3% | +19.8% |
| 波动率 | 64.1% | 32.7% |
| 夏普比率 | 0.45 | 0.60 |
| 索提诺比率 | 0.70 | 0.89 |
| 最大回撤 | -85.1% | -41.6% |
基于 2458 个共同交易日,2016-10-19 → 2026-07-31 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)